Increased expression of human thioredoxin/adult T cell leukemia–derived factor in Sjögren's syndrome
Open Access
- 1 May 1996
- journal article
- clinial science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 39 (5) , 773-782
- https://doi.org/10.1002/art.1780390509
Abstract
Objective. To determine the involvement of human thioredoxi/adult T cell leukemia–derived factor (TRX/ADF) in Sjögren's syndrome (SS) and the correlation with Epstein‐Barr virus (EBV). Methods. Indirect immunohistochemical techniques and reverse transcriptase polymerase chain reaction were utilized to analyze TRX/ADF expression and the presence of EBV, using 6 normal tissues and 23 surgical specimens. The kinetics of expression of TRX/ADF induced by EBV was examined in vitro with peripheral blood B cells from EBV‐seronegative donors. Results. Marked expression of TRX/ADF was found in the infiltrating B cells and the epithelial cells of salivary gland tissues from patients with SS (11 of 12 cases), but not in those from patients with other salivary gland inflammatory conditions (0 of 11 cases) or those of normal individuals (0 of 6 cases). In immunohistologic analyses, a striking topographic correlation between TRX/ADF and EBV was found. The coexistence of TRX/ADF messenger RNA and EBV DNA was detected by polymerase chain reaction (r = 0.75, P < 0.01). Peripheral blood B cells from EBV‐seronegative donors showed de novo synthesis of TRX/ADF following in vitro infection with EBV. EBV‐infected B cell lines all expressed TRX/ADF. TRX/ADF was not detected in non‐EBV‐infected cells. Tumors in SCID mice reconstituted with mononuclear cells of salivary glands from SS patients, which were composed of human B cells carrying EBV DNA, were positive for TRX/ADF. Conclusion. These findings suggest that TRX/ADF expression closely reflects the intracellular event of EBV reactivation in SS. This is also the first report to show the ectopic in vivo expression of TRX/ADF in human autoimmune disease.Keywords
This publication has 44 references indexed in Scilit:
- Spontaneous production of epstein‐barr virus by b lymphoblastoid cell lines obtained from patients with sjögren's syndrome. possible involvement of a novel strain of epstein‐barr virus in disease pathogenesisArthritis & Rheumatism, 1993
- Diseases associated with HTLV-I: virus, IL-2 receptor dysregulation and redox regulationImmunology Today, 1992
- Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: Involvement of dithiol related reductionMolecular Immunology, 1990
- Redox Regulation of Fos and Jun DNA-Binding Activity in VitroScience, 1990
- Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome.The Journal of Experimental Medicine, 1989
- Possible involvement of epstein‐barr virus in polyclonal b cell activation in sjögren's syndromeArthritis & Rheumatism, 1988
- Synthetic peptide derived from the epstein-barr virus encoded early diffuse antigen (ea-d) reactive with human antibodiesJournal of Clinical Laboratory Analysis, 1987
- HLA DR alloantigens in different subsets of patients with Sjögren's syndrome and in family members.Annals of the Rheumatic Diseases, 1983
- Antibodies to ss–b in chronic inflammatory connective tissue diseases. relationship with hla-dw2 and hla–dw3 antigens in primary sjögren's syndromeArthritis & Rheumatism, 1982
- Serologic subsets in systemic lupus erythematosusArthritis & Rheumatism, 1980